SCHEMBL2298795

SCHEMBL2298795

C=Cc1ccc(-c2nnc(N(CC3CC3)C(=O)c3ccc(OC)cc3)s2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 4/20 0.51
ALDH1A1 P00352 9/20 0.48
KDM4E B2RXH2 7/20 0.48
RAB9A P51151 5/20 0.48
NPC1 O15118 5/20 0.48
TP53 P04637 5/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
HPGD P15428 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
HSD17B10 Q99714 5/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 1/20 0.46
CPB1 P15086 1/20 0.45
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2301982 0.91 S1PR1 (0.52) S1PR1ALDH1A1KDM4ERAB9ANPC1
SCHEMBL1966443 0.81 S1PR1 (0.67) S1PR1ALDH1A1KDM4ERAB9ANPC1
SCHEMBL2297250 0.80 S1PR1 (0.53) S1PR1ALDH1A1KDM4ERAB9ANPC1
SCHEMBL2300588 0.79 S1PR1 (0.49) S1PR1ALDH1A1KDM4ERAB9ANPC1
SCHEMBL2297251 0.78 S1PR1 (0.67) S1PR1RAB9ANPC1L3MBTL1
SCHEMBL2299282 0.76 S1PR1 (0.57) S1PR1ALDH1A1KDM4ETP53HSD17B10
SCHEMBL1965593 0.76 S1PR1 (0.65) S1PR1ALDH1A1KDM4ERAB9ANPC1
SCHEMBL13442760 0.76 S1PR1 (0.41) S1PR1ALDH1A1KDM4ERAB9ANPC1
SCHEMBL1965594 0.74 S1PR1 (0.57) S1PR1ALDH1A1KDM4ERAB9ANPC1
SCHEMBL2297213 0.71 S1PR1 (0.54) S1PR1ALDH1A1KDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES S1PR2, S1PR3, S1PR1 S1PR1 3/4885ALDH1A1 1610/4885KDM4E 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.